StreetInsider.com News Articles

Form 144 MACROGENICS INC Filed by: Spitznagel Thomas

Mon, 21 Sep 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260921/27085459.html

MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Wed, 09 Sep 2026 16:05:00 -0400

ROCKVILLE, MD, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will present at the H.C. Wainwright 28th Annual Global Investment Conference on Wednesday, September 16, 2026, at 9:30 a.m. ET.

A webcast of the presentation may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain an archived replay of the webcasts on its website for 30

MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Wed, 09 Sep 2026 16:05:00 -0400

Form 4 MACROGENICS INC For: Aug 19 Filed by: Peters Jeffrey Stuart

Thu, 20 Aug 2026 18:19:00 -0400

si-local-file:///var/storage/secattach/20260820/26957375.html

Form 4 MACROGENICS INC For: Aug 19 Filed by: Peters Jeffrey Stuart

Thu, 20 Aug 2026 18:19:00 -0400

si-local-file:///var/storage/secattach/20260820/26957375.html

Form 144 MACROGENICS INC Filed by: Peters Jeffrey Stuart

Wed, 19 Aug 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260819/26951172.html

Form 144 MACROGENICS INC Filed by: Peters Jeffrey Stuart

Wed, 19 Aug 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260819/26951172.html

Form 4 MACROGENICS INC For: Aug 17 Filed by: Bonvini Ezio

Tue, 18 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260818/26944545.html

Form 4 MACROGENICS INC For: Aug 17 Filed by: Bonvini Ezio

Tue, 18 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260818/26944545.html

Form 144 MACROGENICS INC Filed by: SIEGEL JAY PHILIP

Mon, 17 Aug 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260817/26939048.html

Form 144 MACROGENICS INC Filed by: SIEGEL JAY PHILIP

Mon, 17 Aug 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260817/26939048.html

MacroGenics (MGNX) PT Raised to $11 at B.Riley

Mon, 17 Aug 2026 09:09:40 -0400

B.Riley analyst Mayank Mamtani raised the price target on MacroGenics (NASDAQ: MGNX) to $11.00 (from $9.00) while maintaining a Buy rating.

Form 10-Q MACROGENICS INC For: Jun 30

Fri, 14 Aug 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260814/26931178.html

Form 10-Q MACROGENICS INC For: Jun 30

Fri, 14 Aug 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260814/26931178.html

Form SCHEDULE 13G/A MACROGENICS INC Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:22:00 -0400

si-local-file:///var/storage/secattach/20260814/26926344.html

Form SCHEDULE 13G/A MACROGENICS INC Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:22:00 -0400

si-local-file:///var/storage/secattach/20260814/26926344.html

Macrogenics (MGNX) Misses Q2 EPS by 102c

Thu, 13 Aug 2026 16:23:55 -0400

Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($1.10), $1.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $32.83 million versus the consensus estimate of $59.14 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

Form 8-K MACROGENICS INC For: Aug 13

Thu, 13 Aug 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260813/26920998.html

Form 8-K MACROGENICS INC For: Aug 13

Thu, 13 Aug 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260813/26920998.html

MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position